These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

560 related articles for article (PubMed ID: 23647879)

  • 21. Evaluation of the increase in model for end-stage liver disease (DeltaMELD) score over time as a prognostic predictor in patients with advanced cirrhosis: risk factor analysis and comparison with initial MELD and Child-Turcotte-Pugh score.
    Huo TI; Wu JC; Lin HC; Lee FY; Hou MC; Lee PC; Chang FY; Lee SD
    J Hepatol; 2005 Jun; 42(6):826-32. PubMed ID: 15885353
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [The prognostic value of end-stage liver disease model in liver cirrhosis].
    Zhang JY; Zhang FK; Wang BE; Jia JD; Zhang ST
    Zhonghua Nei Ke Za Zhi; 2005 Nov; 44(11):822-4. PubMed ID: 16316560
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Value of MELD and MELD-based indices in surgical risk evaluation of cirrhotic patients: retrospective analysis of 190 cases.
    Costa BP; Sousa FC; Serôdio M; Carvalho C
    World J Surg; 2009 Aug; 33(8):1711-9. PubMed ID: 19513784
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Model for end-stage liver disease score versus Child score in predicting the outcome of surgical procedures in patients with cirrhosis.
    Hoteit MA; Ghazale AH; Bain AJ; Rosenberg ES; Easley KA; Anania FA; Rutherford RE
    World J Gastroenterol; 2008 Mar; 14(11):1774-80. PubMed ID: 18350609
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Model for end-stage liver disease, model for end-stage liver disease-sodium and Child-Turcotte-Pugh scores over time for the prediction of complications of liver cirrhosis.
    Choi PC; Kim HJ; Choi WH; Park DI; Park JH; Cho YK; Sohn CI; Jeon WK; Kim BI
    Liver Int; 2009 Feb; 29(2):221-6. PubMed ID: 18544124
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Can inclusion of serum creatinine values improve the Child-Turcotte-Pugh score and challenge the prognostic yield of the model for end-stage liver disease score in the short-term prognostic assessment of cirrhotic patients?
    Giannini E; Botta F; Fumagalli A; Malfatti F; Testa E; Chiarbonello B; Polegato S; Bellotti M; Milazzo S; Borgonovo G; Testa R
    Liver Int; 2004 Oct; 24(5):465-70. PubMed ID: 15482344
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Integrated model for end-stage liver disease maybe superior to some other model for end-stage liver disease-based systems in addition to Child-Turcotte-Pugh and albumin-bilirubin scores in patients with hepatitis B virus-related liver cirrhosis and spontaneous bacterial peritonitis.
    Chen PC; Chen BH; Huang CH; Jeng WJ; Hsieh YC; Teng W; Chen YC; Ho YP; Sheen IS; Lin CY
    Eur J Gastroenterol Hepatol; 2019 Oct; 31(10):1256-1263. PubMed ID: 31498284
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Child-Turcotte-Pugh versus model for end stage liver disease score for predicting survival in hospitalized patients with decompensated cirrhosis.
    Chaurasia RK; Pradhan B; Chaudhary S; Jha SM
    J Nepal Health Res Counc; 2013 Jan; 11(23):9-16. PubMed ID: 23787518
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The impact of Model for End-Stage Liver Disease-Na in predicting morbidity and mortality following elective colon cancer surgery irrespective of underlying liver disease.
    Causey MW; Nelson D; Johnson EK; Maykel J; Davis B; Rivadeneira DE; Champagne B; Steele SR
    Am J Surg; 2014 Apr; 207(4):520-6. PubMed ID: 24239525
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Mortality after surgery in patients with liver cirrhosis: comparison of Child-Turcotte-Pugh, MELD and MELDNa score.
    Cho HC; Jung HY; Sinn DH; Choi MS; Koh KC; Paik SW; Yoo BC; Kim SW; Lee JH
    Eur J Gastroenterol Hepatol; 2011 Jan; 23(1):51-9. PubMed ID: 21084989
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Usefulness of model for end-stage liver disease score for predicting mortality after intra-abdominal surgery in patients with liver cirrhosis in a single hospital].
    Song CS; Yoon MY; Kim HJ; Park JH; Park DI; Cho YK; Sohn CI; Jeon WK; Kim BI
    Korean J Gastroenterol; 2011 Jun; 57(6):340-5. PubMed ID: 21694485
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Thyroid hormone levels predict mortality in intensive care patients with cirrhosis.
    Taş A; Köklü S; Beyazit Y; Kurt M; Sayilir A; Yeşil Y; Çelik H
    Am J Med Sci; 2012 Sep; 344(3):175-9. PubMed ID: 22143128
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Comparison of hepatic venous pressure gradient and two models of end-stage liver disease for predicting the survival in patients with decompensated liver cirrhosis.
    Suk KT; Kim CH; Park SH; Sung HT; Choi JY; Han KH; Hong SH; Kim DY; Yoon JH; Kim YS; Baik GH; Kim JB; Kim DJ
    J Clin Gastroenterol; 2012; 46(10):880-6. PubMed ID: 22810110
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Assessing the short- and long-term prognosis of patients with cirrhosis and acute variceal bleeding.
    Sempere L; Palazón JM; Sánchez-Payá J; Pascual S; de Madaria E; Poveda MJ; Carnicer F; Zapater P; Pérez-Mateo M
    Rev Esp Enferm Dig; 2009 Apr; 101(4):236-48. PubMed ID: 19492899
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Clinical value of Child-Turcotte-Pugh and model for end-stage liver disease score to predict the prognosis of chronic severe hepatitis].
    Jiang ZS; Jiang JN
    Zhongguo Wei Zhong Bing Ji Jiu Yi Xue; 2007 Jul; 19(7):412-5. PubMed ID: 17631709
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Correlation and comparison of the model for end-stage liver disease, portal pressure, and serum sodium for outcome prediction in patients with liver cirrhosis.
    Wang YW; Huo TI; Yang YY; Hou MC; Lee PC; Lin HC; Lee FY; Chi CW; Lee SD
    J Clin Gastroenterol; 2007 Aug; 41(7):706-12. PubMed ID: 17667056
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Esophageal Cancer Surgery for Patients with Concomitant Liver Cirrhosis: A Single-Center Matched-Cohort Study.
    Valmasoni M; Pierobon ES; De Pasqual CA; Zanchettin G; Moletta L; Salvador R; Costantini M; Ruol A; Merigliano S
    Ann Surg Oncol; 2017 Mar; 24(3):763-769. PubMed ID: 27704371
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Risk factors for mortality after surgery in patients with cirrhosis.
    Teh SH; Nagorney DM; Stevens SR; Offord KP; Therneau TM; Plevak DJ; Talwalkar JA; Kim WR; Kamath PS
    Gastroenterology; 2007 Apr; 132(4):1261-9. PubMed ID: 17408652
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Early and late outcome of cardiac surgery in patients with liver cirrhosis.
    Filsoufi F; Salzberg SP; Rahmanian PB; Schiano TD; Elsiesy H; Squire A; Adams DH
    Liver Transpl; 2007 Jul; 13(7):990-5. PubMed ID: 17427174
    [TBL] [Abstract][Full Text] [Related]  

  • 40. MELD-based indices as predictors of mortality in chronic liver disease patients who undergo emergency surgery with general anesthesia.
    Kim SH; Han YD; Lee JG; Kim DY; Choi SB; Choi GH; Choi JS; Kim KS
    J Gastrointest Surg; 2011 Nov; 15(11):2029-35. PubMed ID: 21913042
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 28.